First French case of COVID-19 occurred in December, a month earlier than previously thought
May 5, 2020Manufacturing and Production COVID-19, coronavirus
A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …
Scientists in Kenya discover microbe that could stop transmission of malaria
May 5, 2020Manufacturing and Production malaria, mosquitoes
Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from mosquitoes which could pave the …
MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments
May 5, 2020Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
UK contact-tracing app being tested on the Isle of Wight
May 5, 2020Manufacturing and Production COVID-19, coronavirus
The NHS’s coronavirus contract tracing app has been published to Apple and Google’s app stores with council staff and healthcare …
Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer
May 5, 2020Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi
Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …
Working Life Interview: Kim Stratton, CEO, Orphazyme
May 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life
“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …
Lonza and Moderna enter agreement to mass produce coronavirus vaccine
May 4, 2020Sales and Marketing COVID-19, coronavirus
Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …
FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir
Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …
Trump vows to reduce America’s reliance on foreign drug imports
May 4, 2020Sales and Marketing COVID-19, coronavirus
President Donald Trump has vowed to cut the US’s reliance on foreign drugs, singling out China and Ireland as countries …
UK testing experimental treatment for use in COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, coronavirus, coronavirus treatment
British scientists are testing an experimental drug to help some of society’s most vulnerable fight off the COVID-19 coronavirus.
Mike Pompeo says there is evidence COVID-19 was made in a lab, despite US intelligence saying it occurred naturally
May 4, 2020Sales and Marketing COVID-19, Wuhan Institute of virology, coronavirus, lab, pandemic
US Secretary of State Mike Pompeo claimed that there is evidence the COVID-19 coronavirus was created in a lab, despite …
NHS sets out plans to deal with the second phase of the pandemic
May 1, 2020Medical Communications COVID-19, coronavirus
The NHS has set out plans to step up its non-COVID-19 services over the next six weeks. A letter from …
Positive CHMP opinion for BMS and Acceleron’s Reblozyl in transfusion-dependent anaemia sub-populations
May 1, 2020Medical Communications, Sales and Marketing Acceleron, Bristol-Myers Squibb, EU, Reblozyl
Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s Committee for Medicinal …
COVID-19 pandemic likely to last two years, study says
May 1, 2020Medical Communications COVID-19, coronavirus, pandemic
The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds …
Vertex’s Kalydeco seizes EU CHMP recommendation for Kalydeco in R117H+ cystic fibrosis
May 1, 2020Medical Communications, Sales and Marketing Europe, Kalydeco, Vertex, cystic fibrosis
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …
Top Ten most popular articles on Pharmafile.com this week
May 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs
The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …
Teva’s cancer drug Bendeka protected from generics until 2031, judge rules
April 30, 2020Business Services Bendeka, Teva, Teva and Eagle
A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe on four separate patents, and …
AstraZeneca joins forces with University of Oxford to develop and manufacture potential coronavirus vaccine
April 30, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, University of Oxford, coronavirus, pharma
A “landmark” partnership has been struck between AstraZeneca and the University of Oxford in the ongoing battle against COVID-19, with …
More than half of US states will relax lockdowns by the end of the week
April 30, 2020Business Services COVID-19, Lockdown, coronavirus, quaratine
Nearly half of US states will have their ‘stay-at-home’ orders expire this week, paving the way for much of the …
Two studies reveal “positive” data for Gilead’s remdesivir in hospitalised COVID-19 patients
April 30, 2020Research and Development COVID-19, Gilead, coronavirus, remdesivir
The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
